Healthcare robotics, assistive robotics, mobile manipulation, human-robot interaction, intelligent systems that perceive and act.
Our research seeks to advance the capabilities of real robots so that they can provide valued assistance to people in unstructured environments. We work with semi-autonomous mobile robots that physically manipulate the world. Healthcare serves as an important motivating application area for most of our research. Our projects involve research into human-robot interaction, autonomous mobile manipulation, machine perception, machine learning, and haptics.
Dr. Ke's research is highly interdisciplinary combining chemistry, biology, physics, material science, and engineering. The overall mission of his research is to use interdisciplinary research tools to program nucleic-acid-based "beautiful structures and smart devices" at nanoscale, and use them for scientific exploration and technological applications. Specifically, his team focuses on (1) developing new DNA self-assembly paradigms for constructing DNA nanostructures with greater structural complexity, and with controllable sizes and shapes; (2) developing new imaging or drug delivery systems based on DNA nanostructuresl; (3) exploring design of novel DNA-based nanodevices for understanding basic biological questions at molecular level; (4) developing DNA-templated protein devices for constructing artificial bio-reactors.
For cancer-related research/application, Dr. Ke will focus on using DNA/RNA nanostructures as drug delivery vehicles. He is also interested in using DNA/RNA nanostructures to study cancer cell biology at molecular level.
Tissue engineering and biomaterials, microvascular growth and remodeling, stem cell engineering
The Botchwey Laboratory takes a multidisciplinary approach for improvement of tissue engineering therapies through study of microvascular remodeling, inflammation resolution and host stem cells. Our goal is development of effective new strategies to repair, replace, preserve or enhance tissue or organ function.
Immunoengineering, biomaterials, drug delivery, gene delivery, cancer, immunotherapy, tissue engineering, stem cells, regenerative medicine
The overall goal of our research endeavor is the development of new biomaterial-based strategies for gene/drug delivery and stem cell engineering. Towards this, my laboratory focuses on three major directions: (a) design and development of novel delivery systems for nucleic-acid based immunotherapy and cancer chemotherapy (b) engineering complex microenvironments to study and manipulate stem cells and understand their behavior in biomimetic, three-dimensional conditions and (c) developing novel engineering tools and high throughput methods to generate functional T cells and Dendritic cells from stem cells.
Tissue Mechanics Lab (TML) is working to improve the treatment of cardiovascular disease by applying a unique combination of state-of-the-art computational simulations with rigorous experimental evaluation. In the TML, techniques such as planar biaxial testing, tissue fatigue testing, vessel inflation testing, steady and pulsatile cardiac flow testing, and examination of tissue microstructure are used to quantify the mechanical properties of living tissue. This information is then implemented into dynamic solid and fluid simulations. These simulations are being used to better understand how the cardiovascular system works, and how the body interacts with implantable devices.